This inventor holds 3 USPTO granted patents. Top assignee: Nippon Kayaku Kabushiki Kaisha. Active years: 1999-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yono, JP (1999)
- Tokyo, JP (2002)
Company Filing History:
Years Active: 1999-2002
Title: Jouji Sekine: Innovator in Pharmaceutical Chemistry
Introduction
Jouji Sekine is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the production of optically active compounds. With a total of 3 patents to his name, Sekine's work is recognized for its potential applications in drug manufacturing.
Latest Patents
Sekine's latest patents focus on the process for producing highly pure optically active threo-3-amino-1,2-epoxy compounds. These compounds are essential materials for manufacturing drugs. The process involves subjecting an optically active threo-3-amino-1,2-diol derivative in an organic solvent, along with a base, to alkylsulfonylation or arylsulfonylation. This results in the corresponding optically active threo-3-amino-2-hydroxy-1-sulfonyloxy compound. The subsequent step includes epoxidation in the presence of a base, yielding the desired optically active threo-3-amino-1,2-epoxy compound. The final product is purified using an organic solvent and water, resulting in a highly pure epoxy compound.
Career Highlights
Jouji Sekine is associated with Nippon Kayaku Kabushiki Kaisha, a company known for its innovative contributions to the pharmaceutical industry. His work has been instrumental in advancing the methods of producing optically active compounds, which are crucial for drug development.
Collaborations
Sekine has collaborated with notable colleagues, including Yukihiro Sagawa and Hisao Sato. Their combined expertise has further enhanced the research and development efforts within their field.
Conclusion
Jouji Sekine's innovative work in the production of optically active compounds showcases his significant impact on pharmaceutical chemistry. His patents reflect a commitment to advancing drug manufacturing processes, making him a key figure in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
